RyMat Inc
Stuart Silverman
CEO & Founder

RyMat Inc.

Solution Provider to the Pharmaceutical Industry

About Us

Stuart Silverman, CEO & Founder

Solution provider for the Pharmaceutical Industry, specializing in business development, pharmaceutical projects, outsourcing solutions, regulatory assistance, and project management for drug development from concept development through commercial scale manufacturing. Expert witness for patent litigation.Connect on Linked In

RyMat Inc. is your strategic guide providing viable solutions to the pharmaceutical industry, overcoming obstacles and accelerating industry imperative to get products to market faster and smarter. Our scientific, regulatory, and commercial expertise puts best practice standards to work for clients large and small, designing solutions for a constantly evolving healthcare landscape.

With almost 30 years exclusively dedicated to the Pharmaceutical Industry, experience has spanned from Drug Discovery through Commercialization. Academic background in Medicinal Chemistry with a focus on Organic Synthesis.

Successfully transitioned from an individual contributor, bench science role to a cross-functional project team role with external stakeholder responsibilities.

Demonstrated the ability to bridge technical understanding of project details with business requirements. Resulted in ability to effectively communicate results with non-technical business partners while preserving competitive intelligence, intellectual property and business ethics.

Experience with business development, sourcing and compliance management in worldwide markets representing diverse geographical demographics and cultures. Successful record of implementing and managing strategic goals across all phases of drug development and ANDA projects while delivering on value, efficiency and quality compliance. Proven ability to apply technical background, constructive thinking, and resource management to overcome barriers and resolve ambiguity. Extensive career experience that enables an ability to positively influence desired outcomes, operational strategy, and best practices across organizational functions of internal and external business partners. Strong technical and executive level communication skills. Robust project management skills. Employed by global top 20 pharmaceutical companies.

Technical accomplishments include the process development of the HIV drug Sustiva, inception of the first capsule for feminine drug delivery. Guidance for the successful preparation and filing of Drug Master Files, CMC sections, INDs, NDAs, ANDAs, and 505(b)(2) NDAs Additionally providing assistance to help companies develop quality systems for manufacturers and performing mock audits prior to FDA inspections.

Business development lies at the core of helping organizations gain new clients, successfully manage existing customers, and the development of the “hows” and “whys” a client would have the confidence required for successful business. A strong element with respect to the capability to source APIs, advanced intermediates, regulatory starting materials from high quality manufacturers with low cost and low risk.

Shortening time throughout the development process be it for an NDA or ANDA, and in turn helping organizations to preserve resources. 


Justin Patanella

Territory Manager, Sud-Chemie

Stuart was integral to the success of developing dosage form solutions for the Generic and Biotech segments of Capsugel's business within my region. He's a very intelligent individual with a keen sense of urgency and motivation and a nose for the sale. I'd be pleased to work with Stuart again as he is clearly an asset to any organization.

August 26, 2010, Justin worked with Stuart at Capsugel/Pfizer Pharmaceuticals

William J. Frazee

Chemistry Instructor, Part-Time at Madison College

I worked with Stu at the beginning of his professional career in the Medicinal Chemistry group at Zeneca (now AstraZeneca) Pharmaceuticals. Not only was he very hard-working and productive, he had an unusual ability to apply his academic training to the real-world practice of organic synthesis. I recommend Stu very highly for his enthusiasm, his work ethic, and his ability to get useful results.

August 27, 2010, William J. (Jack) managed Stuart at Zeneca Pharmaceuticals